Source: Virtual Congress 2020 – Pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. MacLellan (Glasgow, United Kingdom). The use of genetic testing in an atypical presentation of pulmonary veno-occlusive disease. Virtual Congress 2020 – Pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: An autopsy case of pulmonary veno-occlusive disease refractory to imatinib Source: Eur Respir J 2011; 37: 968-970 Year: 2011 Pulmonary veno-occlusive disease: clinical, functional and hemodynamic characteristics Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007 Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009 Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006 Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 177-180 Year: 2009 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Frequency and impact on prognosis of signs of pulmonary veno-occlusive disease on high resolution computed tomography in patients with scleroderma associated pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Clinical manifestations and prediction rules in patients with pulmonary embolism and prior respiratory disease Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Pulmonary veno-occlusive disease in myeloproliferative disorder Source: Eur Respir J 2009; 33: 213-216 Year: 2009 The peculiarities of etiological verification of pulmonary TB in patients with chronic renal disease in the terminal stage before and after kidney transplantation Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis Source: Eur Respir J 2009; 33: 517-520 Year: 2009 Chronic obstructive pulmonary disease: phenotyping and differential diagnosis Source: International Congress 2018 – Imaging Grand Round Year: 2018 Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Variants of the clinical course of familial pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019